Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis
Authors:
Open Access
- 1 May 2018
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 24 (5) , 937-944
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- SclerodermaNew England Journal of Medicine, 2009
- Cyclophosphamide versus Placebo in Scleroderma Lung DiseaseNew England Journal of Medicine, 2006
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 2005
- Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II studyBritish Journal of Haematology, 2002
- Experimental basis of hematopoietic stem cell transplantation for treatment of autoimmune diseasesJournal of Leukocyte Biology, 2002
- High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomesBlood, 2002
- Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin diseaseAnnals of the Rheumatic Diseases, 2001
- High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trialArthritis & Rheumatism, 1999
- Clinical and Immunologic Effects of Monthly Administration of Intravenous Cyclophosphamide in Severe Systemic Lupus ErythematosusNew England Journal of Medicine, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986